AU2001270631A2 - Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals - Google Patents

Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals

Info

Publication number: AU2001270631A2
Authority: AU; Australia
Prior art keywords: pharmaceuticals; strains; anticancer; parapox ovis; ovis virus
Prior art date: 2000-07-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001270631A

Other versions

AU2001270631A1 (en

AU2001270631B2 (en

Inventor

Claudia Hirth-Dietrich

Andreas Knorr

Tobias Schlapp

Angela Siegling

Gudrun Theiss

Hans-Dieter Volk

Olaf Weber

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer AG

Original Assignee

Bayer AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-11

Filing date

2001-07-11

Publication date

2003-05-29

2001-05-09 Priority claimed from DE10122451A external-priority patent/DE10122451A1/en

2001-07-11 Application filed by Bayer AG filed Critical Bayer AG

2001-07-11 Priority claimed from PCT/EP2001/007991 external-priority patent/WO2002004002A2/en

2002-04-18 Publication of AU2001270631A1 publication Critical patent/AU2001270631A1/en

2003-05-29 Publication of AU2001270631A2 publication Critical patent/AU2001270631A2/en

2005-07-07 Application granted granted Critical

2005-07-07 Publication of AU2001270631B2 publication Critical patent/AU2001270631B2/en

2021-07-11 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE10033582		2000-07-11
DE10033582		2000-07-11
DE10122451		2001-05-09
DE10122451A DE10122451A1 (en)	2000-07-11	2001-05-09	Use of strains of the Parapoxvirus ovis for the production of antiviral and anti-cancer drugs
PCT/EP2001/007991 WO2002004002A2 (en)	2000-07-11	2001-07-11	Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals

Publications (3)

Publication Number	Publication Date
AU2001270631A1 AU2001270631A1 (en)	2002-04-18
AU2001270631A2 true AU2001270631A2 (en)	2003-05-29
AU2001270631B2 AU2001270631B2 (en)	2005-07-07

Family

ID=26006335

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU7063101A Pending AU7063101A (en)	2000-07-11	2001-07-11	Use of strains of the parapox ovis virus for producing antiviral pharmaceuticalsand anticancer pharmaceuticals
AU2001270631A Expired - Fee Related AU2001270631B2 (en)	2000-07-11	2001-07-11	Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU7063101A Pending AU7063101A (en)	2000-07-11	2001-07-11	Use of strains of the parapox ovis virus for producing antiviral pharmaceuticalsand anticancer pharmaceuticals

Country Status (36)

Country	Link
US (1)	US6685950B2 (en)
EP (1)	EP1303286B1 (en)
JP (1)	JP5037775B2 (en)
CN (1)	CN1455674B (en)
AR (1)	AR029954A1 (en)
AT (1)	ATE324115T1 (en)
AU (2)	AU7063101A (en)
BG (1)	BG107448A (en)
CA (1)	CA2415397C (en)
CY (1)	CY1105408T1 (en)
CZ (1)	CZ200371A3 (en)
DE (1)	DE50109630D1 (en)
DK (2)	DK1303286T3 (en)
EE (1)	EE200300018A (en)
ES (1)	ES2262663T3 (en)
FI (1)	FI20030037A7 (en)
GB (1)	GB2381454B8 (en)
HK (1)	HK1054329B (en)
HR (1)	HRP20030096A2 (en)
HU (1)	HUP0400479A3 (en)
IL (1)	IL153643A0 (en)
LT (1)	LT5079B (en)
LU (1)	LU90997B1 (en)
LV (1)	LV12990B (en)
MA (1)	MA26927A1 (en)
MX (1)	MXPA03000279A (en)
NO (1)	NO20030082L (en)
NZ (1)	NZ523534A (en)
PL (1)	PL366397A1 (en)
PT (1)	PT1303286E (en)
RU (1)	RU2003104525A (en)
SE (1)	SE0300034L (en)
SI (1)	SI21122A (en)
SK (1)	SK362003A3 (en)
UY (1)	UY26832A1 (en)
WO (1)	WO2002004002A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19922407A1 (en) *	1999-05-14	2000-11-16	Bayer Ag	Preparing medicament for treating viral infections, liver diseases or cancer, comprising recombinant parapoxvirus targeted towards specific organs, cells or tissues
CN101676389A (en) *	2000-11-23	2010-03-24	巴法里安诺迪克有限公司	Modified vaccinia ankara virus variant
US7628980B2 (en) *	2000-11-23	2009-12-08	Bavarian Nordic A/S	Modified vaccinia virus ankara for the vaccination of neonates
US7097842B2 (en) *	2000-11-23	2006-08-29	Bavarian Nordic A/S	Modified vaccinia virus ankara for the vaccination of neonates
NZ512341A (en) *	2001-06-13	2004-02-27	Bayer Ag	Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments
WO2003049683A2 (en)	2001-12-07	2003-06-19	Bayer Pharmacueticals Corporation	Use of parapox b2l protein to treat cancer and modify immune responses
PL220781B1 (en) *	2002-04-19	2016-01-29	Bavarian Nordic As	Modified vaccinia virus ankara for the vaccination of neonates
DK1434858T4 (en) *	2002-09-05	2019-04-01	Bavarian Nordic As	PROCEDURE FOR AMPLIFICATION OF A POXVIRUS UNDER SERUM-FREE CONDITIONS
DK1765370T3 (en) *	2004-07-13	2009-11-02	Aicuris Gmbh & Co Kg	Parapox viruses in combination with other antiviral agents for the treatment of HIV / AIDS
JP5164849B2 (en) *	2005-11-24	2013-03-21	アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト	Parapoxviruses combined with classic cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer
JP5004990B2 (en) *	2009-03-31	2012-08-22	アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト	Recombinant protein of parapoxvirus Ovis and pharmaceutical composition derived therefrom
WO2011072871A1 (en) *	2009-12-18	2011-06-23	Bavarian Nordic A/S	Production of ifn-lambda by conventional dendritic cells and uses thereof
JP5699093B2 (en) *	2012-01-05	2015-04-08	アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフトＡｉＣｕｒｉｓＧｍｂＨ＆Ｃｏ．ＫＧ	Recombinant protein of parapoxvirus Ovis and pharmaceutical composition derived therefrom
TW201919675A (en) *	2017-09-07	2019-06-01	德商艾庫瑞斯公司	Combination therapies of hepatitis B virus (HBV)-infected individuals using Parapoxvirus ovis (PPVO) and at least one further antiviral drug
WO2023083950A1 (en) *	2021-11-10	2023-05-19	Aicuris Gmbh & Co. Kg	Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with immunomodulators
WO2023083943A1 (en) *	2021-11-10	2023-05-19	Aicuris Gmbh & Co. Kg	Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with antivirals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2714665A1 (en) *	1977-04-01	1978-10-05	Mayr Anton	PREPARATION FOR TREATING HERPES ZOSTER AND OTHER HERPES INFECTIONS AND METHOD FOR THE PRODUCTION THEREOF
DE3504940C2 (en) *	1984-02-17	1997-11-06	Bayer Ag	Multipotent paramunity mediators, processes for their preparation and medicaments containing these mediators
US5443964A (en) *	1987-08-10	1995-08-22	Duke University	Poxvirus insertion/expression vector
DE4405841C1 (en) *	1994-02-23	1995-01-05	Mayr Anton Prof Dr Med Vet Dr	Multipotent non-specific immunity inducers based on combinations of poxvirus components, processes for their preparation and their use as pharmaceuticals
US5648101A (en) *	1994-11-14	1997-07-15	Tawashi; Rashad	Drug delivery of nitric oxide
WO1997032029A1 (en) *	1996-02-28	1997-09-04	Bayer Aktiengesellschaft	Parapoxviruses containing foreign dna, their production and their use in vaccines
CN1217751A (en) *	1996-03-29	1999-05-26	奥塔戈大学	Parapoxvirus vectors
JP3568208B2 (en) *	1996-04-15	2004-09-22	マイヤー，アントン	Novel efficacy for the use of multipotent parapox immunity inducers from attenuated non-immunogenic poxviruses or parapoxviruses as drugs
SE9700617D0 (en) *	1997-02-21	1997-02-21	Kjell Alving	New composition
DE19843222A1 (en) *	1998-09-22	2000-03-30	Hassan Jomaa	Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections
DE69931178T8 (en) *	1998-11-02	2007-06-28	Ludwig Institute For Cancer Research	A VIRUS NZ10 ORF VIRUS NZ10 PROTEIN RELATED TO THE VASCULAR ENDOTHELIC GROWTH FACTOR BINDS AND ACTIVATES THE MAMMAL VEGF RECEPTOR-2

2001
- 2001-07-11 SK SK36-2003A patent/SK362003A3/en not_active Application Discontinuation
- 2001-07-11 PL PL01366397A patent/PL366397A1/en not_active Application Discontinuation
- 2001-07-11 EP EP01949489A patent/EP1303286B1/en not_active Expired - Lifetime
- 2001-07-11 AT AT01949489T patent/ATE324115T1/en active
- 2001-07-11 IL IL15364301A patent/IL153643A0/en active IP Right Grant
- 2001-07-11 GB GB0302630A patent/GB2381454B8/en not_active Expired - Fee Related
- 2001-07-11 NZ NZ523534A patent/NZ523534A/en not_active IP Right Cessation
- 2001-07-11 AU AU7063101A patent/AU7063101A/en active Pending
- 2001-07-11 FI FI20030037A patent/FI20030037A7/en not_active IP Right Cessation
- 2001-07-11 EE EEP200300018A patent/EE200300018A/en unknown
- 2001-07-11 SI SI200120048A patent/SI21122A/en not_active IP Right Cessation
- 2001-07-11 HR HR20030096A patent/HRP20030096A2/en not_active Application Discontinuation
- 2001-07-11 LU LU90997A patent/LU90997B1/en active
- 2001-07-11 JP JP2002508456A patent/JP5037775B2/en not_active Expired - Lifetime
- 2001-07-11 AR ARP010103292A patent/AR029954A1/en unknown
- 2001-07-11 HK HK03106613.1A patent/HK1054329B/en not_active IP Right Cessation
- 2001-07-11 RU RU2003104525/15A patent/RU2003104525A/en not_active Application Discontinuation
- 2001-07-11 HU HU0400479A patent/HUP0400479A3/en unknown
- 2001-07-11 US US09/903,013 patent/US6685950B2/en not_active Expired - Lifetime
- 2001-07-11 WO PCT/EP2001/007991 patent/WO2002004002A2/en not_active Ceased
- 2001-07-11 AU AU2001270631A patent/AU2001270631B2/en not_active Expired - Fee Related
- 2001-07-11 ES ES01949489T patent/ES2262663T3/en not_active Expired - Lifetime
- 2001-07-11 PT PT01949489T patent/PT1303286E/en unknown
- 2001-07-11 UY UY26832A patent/UY26832A1/en not_active Application Discontinuation
- 2001-07-11 DE DE50109630T patent/DE50109630D1/en not_active Expired - Lifetime
- 2001-07-11 CN CN01812685.5A patent/CN1455674B/en not_active Expired - Lifetime
- 2001-07-11 CZ CZ200371A patent/CZ200371A3/en unknown
- 2001-07-11 MX MXPA03000279A patent/MXPA03000279A/en unknown
- 2001-07-11 DK DK01949489T patent/DK1303286T3/en active
- 2001-07-11 CA CA2415397A patent/CA2415397C/en not_active Expired - Lifetime
2003
- 2003-01-08 BG BG107448A patent/BG107448A/en unknown
- 2003-01-08 NO NO20030082A patent/NO20030082L/en unknown
- 2003-01-10 MA MA26994A patent/MA26927A1/en unknown
- 2003-01-10 SE SE0300034A patent/SE0300034L/en not_active Application Discontinuation
- 2003-01-10 DK DK200300015A patent/DK200300015A/en not_active Application Discontinuation
- 2003-02-03 LT LT2003009A patent/LT5079B/en not_active IP Right Cessation
- 2003-02-11 LV LVP-03-14A patent/LV12990B/en unknown
2006
- 2006-07-24 CY CY20061101024T patent/CY1105408T1/en unknown

Publication	Publication Date	Title
AU2001270631A1 (en)	2002-04-18	Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
AU2001270631A2 (en)	2003-05-29	Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
HUP0400479A3 (en)	2006-02-28	Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
AU2001244675A1 (en)	2001-10-08	Aids virus vaccine with the use of sendai virus vector
AU2001238501A1 (en)	2001-08-27	Selective destruction of cells infected with human immunodeficiency virus
AU6625400A (en)	2001-04-30	Catalyst preparation and epoxidation process
AU5428700A (en)	2001-01-31	Acrylic acid derivatives, use of the same and intermediates for the preparation thereof
AU2002225509A1 (en)	2003-06-17	Production and of viruses, viral isolates and vaccines
AU5827000A (en)	2001-02-05	Viral il-10 uses
AU5368699A (en)	2000-11-02	Derivatives of triptolide, and preparation and uses thereof
AU2001285827A2 (en)	2003-05-29	Use of strains of the parapox ovis virus against organ fibrosis
AU2001285827A1 (en)	2002-04-18	Use of strains of the parapox ovis virus against organ fibrosis
LU90996B1 (en)	2003-01-08	Use of the strains of the parapox ovis virus against fibrosis
ZA200205470B (en)	2003-10-29	Virus strains for the oncolytic treatment of cancer.
AU2003276139A1 (en)	2005-05-19	The use of ir, near ir, visible and uv radiation for the preparation of catalysts
AU5277199A (en)	2000-10-23	Supergravitational field vortex reactor and the use thereof
AU3714800A (en)	2000-09-21	Hiv therapy
AU2002308105A1 (en)	2003-04-10	Benzoaxathiepin derivatives and their use as medicines
AU2002314274A1 (en)	2003-05-08	Vaccination against the feline immunodeficiency virus
AU2001297753A1 (en)	2002-10-21	Yeast genes that affect viral replication
AU2488600A (en)	2000-07-24	Endophyte and grass infected by the same
HK1065333A (en)	2005-02-18	Production of viruses, viral isolates and vaccines
AU782659C (en)	2012-04-26	Herpes virus strains for gene therapy
AU2002255937A1 (en)	2002-10-08	Methods for the treatment of hiv and other viruses
GB0100430D0 (en)	2001-02-21	Virus strains